Forward Industries, Inc. filed a Form 8-K with the SEC on September 15, 2026, disclosing that it issued a press release announcing an updated proposal to acquire SkyAI, Inc.
Civista Bancshares, Inc. filed a Form 8-K on September 15, 2026, announcing that it plans to release its third quarter 2026 financial results prior to market open on October 22, 2026.
Natural Grocers by Vitamin Cottage, Inc. filed an 8-K on September 15, 2026, disclosing that majority stockholders acted by written consent on September 9, 2026, to approve the company's reincorporation from Delaware to Texas by conversion.
Talon Capital Corp. filed a Form 8-K on September 15, 2026, disclosing the appointment of Dr. Victoria Ivashina as an independent director and audit committee member, effective September 11, 2026.
nVent Electric plc filed a Form 8-K current report with the SEC on September 15, 2026, disclosing information related to the planned acquisition of Maverick Power, LLC, with excerpts from a preliminary prospectus supplement attached as Exhibit 99.1.
Director Geoffrey M. Parker filed a Form 4 with the SEC on September 15, 2026, reporting transactions in Perrigo Company plc ordinary shares on September 11, 2026, related to the vesting of Restricted Stock Units.
Director Bradley A. Alford of Perrigo Company plc filed a Form 4 on September 15, 2026, reporting transactions in ordinary shares and restricted stock units dated September 11, 2026, on NYSE:PRGO.
A Form 4 filed on September 15, 2026, discloses that Arthur L. Money, a director of HawkEye 360, Inc. (HAWK), exercised stock options and sold common stock on September 11, 2026.
A Form 4 filed on September 15, 2026 reports that Naimish Patel, a director of AgomAb Therapeutics NV (NASDAQ:AGMB), was granted stock options on September 11, 2026.
A Form 4 filed with the SEC on September 15, 2026 discloses that Marino Garcia, a director of AgomAb Therapeutics NV (NASDAQ:AGMB), was granted stock options on September 11, 2026.